- Recorded webcast
New EU GMP Annex 1 and its Impact on Pharmaceutical Manufacturers
Free
Recorded webcast
This free webinar will explain the reasons for the revision of Annex 1 and will address the changes and implications for pharmaceutical manufacturers. Topics to be covered will include how to prepare your Contamination Control Strategy (CCS) document, and how to adapt to the principles of Quality Risk Management. The expectations of the regulatory authorities and the questions that may be encountered in audits/inspections will also be discussed.
- 1.5 CPD hours Bite-size
-
Presented by Mr Mustafa Edik
- Next: 19-21 May 2026 Live online
- Also: 24-26 Nov 2026 Live online
New EU GMP Annex 1: Compliant Sterile Medicinal Products
Live online
Maintaining a sterile production environment on an ongoing basis is critical in the production of sterile pharmaceuticals, and strict adherence to guidelines and relevant standards is required to minimize contamination risks and ensure product quality and safety. During this training, all changes in Annex 1 will be evaluated, and the minimum requirements that aseptic operations must meet will be discussed and presented to the participants through examples.
- 18 CPD hours Focused
-
Presented by Mr Mustafa Edik
- Recorded webcast
In the Light of Annex 1: Use of Barrier Systems for Aseptic Pharmaceutical Manufacturing
Free
Recorded webcast
This free webinar will familiarise attendees with Restricted Access Barrier System (RABS) technologies. An excellent opportunity to receive detailed information about barrier systems with a main focus on isolator technology, particularly since the implementation of EU GMP Annex 1.
- 1.5 CPD hours Bite-size
-
Presented by Lukas Munzinger